Items tagged with Access
South Korea OKs Eugene Bell Foundation's plan to send TB medication to North Korea (post)
South Korea's Unification Ministry has approved an application by the Eugene Bell Foundation Korea to send medication for tuberculosis to North Korea, a government official said Wednesday (January 18).
Bedaquiline debate: Domicile requirement for TB patients to get live-saving drug may no longer apply (post)
An unreasonable domicile requirement that was responsible for denying the life-saving bedaquiline drug to many patients suffering from drug-resistant tuberculosis may no longer apply.
Statement from The Union on bedaquiline access, India (post)
Paris, France, 19 January 2017– Drug-resistant TB is one of the most terrible diseases that any person can ever face. Even when treatment is effective, it is long and very difficult. The health system must do everything in its power to provide access to effective treatments for every patient, with the appropriate treatment depending on the drug susceptibility profile involved in each case. It is essential that drug-sensitivity testing be performed at the outset, so that healthcare workers and patients know which medicines are likely to be effective in treatment and which will not be effective due to resistance. People living with drug-resistant TB should receive only those TB medicines that are likely to be effective in the case of that patient, and they must be treated with multiple medicines, at the same time, to which the TB is susceptible—a treatment approach known as “combination therapy”.
Essential medicines for universal health coverage (post)
Executive summary
U.S. government introduces new drug to help save lives of TB patients in Tajikistan (post)
Acting Deputy Chief of Mission of the United States to Tajikistan Lucy Jilka yesterday (January 31) joined the First Deputy Minister of Health and Social Protection of Population of Tajikistan Saida Umarzoda, national health leadership, physicians, TB doctors, and stakeholders to celebrate the introduction of bedaquiline to Tajikistan. This is the first new drug approved for the treatment of tuberculosis (TB) since the 1960s.
India plans to expand access to new TB drug (post)
The Government of India is planning to increase access to a new drug for drug-resistant TB after a landmark court ruling. Dinesh C Sharma reports from New Delhi.
UNITAID invites proposals that help countries use trade rules to increase access to drugs (post)
GENEVA, Feb 20 – Unitaid launched a new call for proposals to help countries take advantage of provisions under global intellectual property rules that allow increased access to affordable medicines in order to safeguard public health.
India: ‘Fast-track approvals for TB, hepatitis, HIV drugs on the anvil’ (post)
If drugs in these categories have received regulatory approvals in other markets, the government will fast track their clearance here to speed up local access: Drug Controller General
South Africa scores new medicine worth millions – for free (post)
Drugmaker Otsuka Pharmaceutical won’t charge South Africa for using its new tuberculosis (TB) drug in a pilot programme, but South Africa’s free deal is unlikely to last.
Despite 2 ‘miracle’ drugs, TB patient dies after long battle (post)
A 19-year-old tuberculosis (TB) patient who was among the first in India to receive both Bedaquiline and Delamanid drugs died last month after battling the infection for a prolonged period. In her final days, she was on oxygen support after doctors labelled her as “therapeutically incurable”.
Page 27 of 83 · Total posts: 0
←First 26 27 28 Last→